Literature DB >> 23301201

microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF).

Peter N Alexandrov1, Prerna Dua, James M Hill, Surjyadipta Bhattacharjee, Yuhai Zhao, Walter J Lukiw.   

Abstract

Human cerebrospinal fluid (CSF), produced by the choroid plexus and secreted into the brain ventricles and subarachnoid space, plays critical roles in intra-cerebral transport and the biophysical and immune protection of the brain. CSF composition provides valuable insight into soluble pathogenic bio-markers that may be diagnostic for brain disease. In these experiments we analyzed amyloid beta (Aβ) peptide and micro RNA (miRNA) abundance in CSF and in short post-mortem interval (PMI <2.1 hr) brain tissue-derived extracellular fluid (ECF) from Alzheimer's disease (AD) and age-matched control neocortex. There was a trend for decreased abundance of Aβ42 in the CSF and ECF in AD but it did not reach statistical significance (mean age ~72 yr; N=12; p~0.06, ANOVA). The most abundant nucleic acids in AD CSF and ECF were miRNAs, and their speciation and inducibility were studied further. Fluorescent miRNA-array-based analysis indicated significant increases in miRNA-9, miRNA-125b, miRNA-146a, miRNA-155 in AD CSF and ECF (N=12; p<0.01, ANOVA). Primary human neuronal-glial (HNG) cell co-cultures stressed with AD-derived ECF also displayed an up-regulation of these miRNAs, an effect that was quenched using the anti-NF-кB agents caffeic acid phenethyl ester (CAPE) or 1-fluoro-2-[2-(4-methoxy-phenyl)-ethenyl]-benzene (CAY10512). Increases in miRNAs were confirmed independently using a highly sensitive LED-Northern dot-blot assay. Several of these NF-кB-sensitive miRNAs are known to be up-regulated in AD brain, and associate with the progressive spreading of inflammatory neurodegeneration. The results indicate that miRNA-9, miRNA-125b, miRNA-146a and miRNA-155 are CSF- and ECF-abundant, NF-кB-sensitive pro-inflammatory miRNAs, and their enrichment in circulating CSF and ECF suggest that they may be involved in the modulation or proliferation of miRNA-triggered pathogenic signaling throughout the brain and central nervous system (CNS).

Entities:  

Keywords:  Alzheimer’s disease (AD); CAPE (caffeic acid phenethyl ester); CAY10512 (1-fluoro-2-[2-(4-methoxyphenyl)-ethenyl]-benzene); NF-кB; inflammatory signaling; micro RNA

Year:  2012        PMID: 23301201      PMCID: PMC3533883     

Source DB:  PubMed          Journal:  Int J Biochem Mol Biol        ISSN: 2152-4114


  43 in total

Review 1.  MicroRNAs in Alzheimer's disease.

Authors:  Charlotte Delay; Wim Mandemakers; Sébastien S Hébert
Journal:  Neurobiol Dis       Date:  2012-01-17       Impact factor: 5.996

Review 2.  Identifying earlier Alzheimer's disease: insights from the preclinical and prodromal phases.

Authors:  Jose Luis Molinuevo; Raquel Sánchez-Valle; Albert Lladó; Juan Fortea; David Bartrés-Faz; Lorena Rami
Journal:  Neurodegener Dis       Date:  2011-12-07       Impact factor: 2.977

3.  Expression of inflammatory genes in the primary visual cortex of late-stage Alzheimer's disease.

Authors:  Jian-Guo Cui; James M Hill; Yuhai Zhao; Walter J Lukiw
Journal:  Neuroreport       Date:  2007-01-22       Impact factor: 1.837

Review 4.  Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders.

Authors:  Mathias Jucker; Lary C Walker
Journal:  Ann Neurol       Date:  2011-10       Impact factor: 10.422

5.  Mammalian microRNAs predominantly act to decrease target mRNA levels.

Authors:  Huili Guo; Nicholas T Ingolia; Jonathan S Weissman; David P Bartel
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

6.  Micro-RNA-128 (miRNA-128) down-regulation in glioblastoma targets ARP5 (ANGPTL6), Bmi-1 and E2F-3a, key regulators of brain cell proliferation.

Authors:  J G Cui; Y Zhao; P Sethi; Y Y Li; A Mahta; F Culicchia; W J Lukiw
Journal:  J Neurooncol       Date:  2009-11-26       Impact factor: 4.130

7.  Molecular shuttle chelation: the use of ascorbate, desferrioxamine and Feralex-G in combination to remove nuclear bound aluminum.

Authors:  Theo P Kruck; Jian-Guo Cui; Maire E Percy; Walter J Lukiw
Journal:  Cell Mol Neurobiol       Date:  2004-06       Impact factor: 5.046

Review 8.  New evidence for an active role of aluminum in Alzheimer's disease.

Authors:  D R McLachlan; W J Lukiw; T P Kruck
Journal:  Can J Neurol Sci       Date:  1989-11       Impact factor: 2.104

Review 9.  Identifying and validating biomarkers for Alzheimer's disease.

Authors:  Christian Humpel
Journal:  Trends Biotechnol       Date:  2010-10-23       Impact factor: 19.536

10.  Carbodiimide-mediated cross-linking of RNA to nylon membranes improves the detection of siRNA, miRNA and piRNA by northern blot.

Authors:  Gurman Singh Pall; Carles Codony-Servat; Jane Byrne; Leigh Ritchie; Andrew Hamilton
Journal:  Nucleic Acids Res       Date:  2007-04-02       Impact factor: 16.971

View more
  102 in total

1.  miR-146a Dysregulates Energy Metabolism During Neuroinflammation.

Authors:  Sujung Jun Kim; Ashley E Russell; Wei Wang; Darren E Gemoets; Saumyendra N Sarkar; James W Simpkins; Candice M Brown
Journal:  J Neuroimmune Pharmacol       Date:  2021-05-24       Impact factor: 4.147

2.  microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease.

Authors:  Aaron D Thome; Ashley S Harms; Laura A Volpicelli-Daley; David G Standaert
Journal:  J Neurosci       Date:  2016-02-24       Impact factor: 6.167

Review 3.  Exploring Biomarkers for Alzheimer's Disease.

Authors:  Neeti Sharma; Anshika Nikita Singh
Journal:  J Clin Diagn Res       Date:  2016-07-01

Review 4.  Role of viruses, prions and miRNA in neurodegenerative disorders and dementia.

Authors:  Sayed Sartaj Sohrab; Mohd Suhail; Ashraf Ali; Mohammad Amjad Kamal; Azamal Husen; Fahim Ahmad; Esam Ibraheem Azhar; Nigel H Greig
Journal:  Virusdisease       Date:  2018-09-29

Review 5.  Cerebrospinal Fluid Biomarkers of Alzheimer's Disease: Current Evidence and Future Perspectives.

Authors:  Donovan A McGrowder; Fabian Miller; Kurt Vaz; Chukwuemeka Nwokocha; Cameil Wilson-Clarke; Melisa Anderson-Cross; Jabari Brown; Lennox Anderson-Jackson; Lowen Williams; Lyndon Latore; Rory Thompson; Ruby Alexander-Lindo
Journal:  Brain Sci       Date:  2021-02-10

6.  miR-151-5p modulates APH1a expression to participate in contextual fear memory formation.

Authors:  Xu-Feng Xu; You-Cui Wang; Liang Zong; Xiao-Long Wang
Journal:  RNA Biol       Date:  2019-01-29       Impact factor: 4.652

7.  CSF microRNA Profiling in Alzheimer's Disease: a Screening and Validation Study.

Authors:  Adrià Dangla-Valls; José Luis Molinuevo; Jordi Altirriba; Raquel Sánchez-Valle; Daniel Alcolea; Juan Fortea; Lorena Rami; Mircea Balasa; Cristina Muñoz-García; Mario Ezquerra; Rubén Fernández-Santiago; Alberto Lleó; Albert Lladó; Anna Antonell
Journal:  Mol Neurobiol       Date:  2016-10-13       Impact factor: 5.590

Review 8.  A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer's disease.

Authors:  P Hemachandra Reddy; Sahil Tonk; Subodh Kumar; Murali Vijayan; Ramesh Kandimalla; Chandra Sekhar Kuruva; Arubala P Reddy
Journal:  Biochem Biophys Res Commun       Date:  2016-08-12       Impact factor: 3.575

Review 9.  Biomarkers in Alzheimer's disease analysis by mass spectrometry-based proteomics.

Authors:  Yahui Liu; Hong Qing; Yulin Deng
Journal:  Int J Mol Sci       Date:  2014-05-06       Impact factor: 5.923

Review 10.  Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer's disease (AD) and in primary human neuronal-glial (HNG) cells.

Authors:  Yuhai Zhao; Surjyadipta Bhattacharjee; Brandon M Jones; Jim Hill; Prerna Dua; Walter J Lukiw
Journal:  Mol Neurobiol       Date:  2013-11-29       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.